...
首页> 外文期刊>AORN journal >Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy, Part II II : Implementation
【24h】

Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy, Part II II : Implementation

机译:具有高温腹膜内化疗的细胞功能术手术,第二部分II:实施

获取原文
获取原文并翻译 | 示例

摘要

ABSTRACT Cytoreductive surgery ( CRS ) with hyperthermic intraperitoneal chemotherapy ( HIPEC ) is an extensive procedure used to treat peritoneal carcinomatosis, which is either primary or secondary to other cancers (eg, ovarian, colorectal, appendiceal) that have metastasized to the peritoneum. Morbidity, mortality, and quality of life have improved for patients selecting CRS with HIPEC as a cancer treatment. At Holy Name Medical Center in Teaneck, New Jersey, an interdisciplinary team was established to plan and coordinate performing this new procedure in the OR . The team created a written protocol for implementing CRS with HIPEC before patients were scheduled for surgery. This article explores the perioperative facets of implementing CRS with HIPEC and discusses care of the patient undergoing CRS with HIPEC , with a focus on perioperative nursing considerations.
机译:摘要具有高温腹膜内化疗(HIPEC)的细胞功能术外科(CRS)是用于治疗腹膜癌症的广泛程序,其是初级或继发于其转移到腹膜的癌症(例如,卵巢,结直肠,阑尾)。 为患有高症患者作为癌症治疗的患者提供了发病率,死亡率和生活质量。 在新泽西州Teaneck的Holy名称医疗中心,建立了一个跨学科团队,计划和协调在或。 该团队在患者预定手术之前创建了一份书面协议,以便在患者进行手术前进行高度。 本文探讨了具有高度高度的CRS的围手术期方面,并讨论了高度高度接受CRS的患者的护理,重点是围手术期护理考虑因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号